Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia

Cristina Giannattasio, Arduino A. Mangoni, Monica Failla, Stefano Carugo, Maria Luisa Stella, Patrizia Stefanoni, Guido Grassi, Carlo Vergani, Giuseppe Mancia

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Hypercholesterolemia impairs arteriolar dilatation, but whether the vascular abnormalities accompanying this condition include large artery function is unknown. We addressed this issue in 13 normotensive subjects with familial hypercholesterolemia (serum cholesterol 401.6 ± 16.9 mg/dl, mean ± S.E., FHC) and no evidence of atherosclerotic lesions, in whom radial artery (RA) diameter and blood pressure (BP) were measured beat to beat by an echotracking and a Finapres device, respectively. RA compliance (RAG) was derived from the diameter/BP relationship and expressed over the systo-diastolic BP range, both at baseline and after a 12-min brachial artery occlusion. RAC was expressed also as the area under the RAC/BP curve divided for pulse BP. Measurements included maximal forearm blood flow (plethysmography) and minimal forearm vascular resistance (FVR) which were obtained from the values following the 12-min brachial arterial occlusion. Data were collected before and after 6- and 24-month lipid lowering treatment (simvastatin 40 mg/day). Ten age-matched normotensive normocholesterolemic healthy subjects (N) served as controls. Compared to N, baseline RAC was strikingly reduced in FHC (-53.5%, P <0.01). After ischemia RAC increased significantly and markedly in N (+38.7, P <0.01), while only a modest and non-significant increase was observed in FHC. Minimal FVR was markedly higher in FHC than in N (3.5 ± 0.9 vs 1.6 ± 0.1 units, P <0.01). In FHC (7 subjects) RAC remained unchanged after 6 months of lipid lowering treatment, but increased markedly (+55.2%, P <0.05) when treatment was prolonged to 24 months. Lipid lowering treatment also reduced minimal FVR, the effect being significant bath after 6 and after 24 months. No changes in RAC and minimal FVR were seen after 6 months in controls. Thus, in subjects with a marked increase in serum cholesterol due to FHC, not only arteriolar dilatation, but also RAC and distensibility are markedly impaired. This impairment can be favourably affected by an effective lipid lowering treatment of long duration.

Original languageEnglish
Pages (from-to)249-260
Number of pages12
JournalAtherosclerosis
Volume124
Issue number2
DOIs
Publication statusPublished - Aug 2 1996

Fingerprint

Hyperlipoproteinemia Type II
Radial Artery
Compliance
Forearm
Blood Pressure
Vascular Resistance
Lipids
Dilatation
Cholesterol
Therapeutics
Simvastatin
Plethysmography
Brachial Artery
Hypercholesterolemia
Serum
Baths
Blood Vessels
Healthy Volunteers
Arm
Ischemia

Keywords

  • Arterial compliance
  • Familial hypercholesterolemia
  • Lipid profile
  • Peripheral circulation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Giannattasio, C., Mangoni, A. A., Failla, M., Carugo, S., Stella, M. L., Stefanoni, P., ... Mancia, G. (1996). Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia. Atherosclerosis, 124(2), 249-260. https://doi.org/10.1016/0021-9150(96)05834-0

Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia. / Giannattasio, Cristina; Mangoni, Arduino A.; Failla, Monica; Carugo, Stefano; Stella, Maria Luisa; Stefanoni, Patrizia; Grassi, Guido; Vergani, Carlo; Mancia, Giuseppe.

In: Atherosclerosis, Vol. 124, No. 2, 02.08.1996, p. 249-260.

Research output: Contribution to journalArticle

Giannattasio, C, Mangoni, AA, Failla, M, Carugo, S, Stella, ML, Stefanoni, P, Grassi, G, Vergani, C & Mancia, G 1996, 'Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia', Atherosclerosis, vol. 124, no. 2, pp. 249-260. https://doi.org/10.1016/0021-9150(96)05834-0
Giannattasio C, Mangoni AA, Failla M, Carugo S, Stella ML, Stefanoni P et al. Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia. Atherosclerosis. 1996 Aug 2;124(2):249-260. https://doi.org/10.1016/0021-9150(96)05834-0
Giannattasio, Cristina ; Mangoni, Arduino A. ; Failla, Monica ; Carugo, Stefano ; Stella, Maria Luisa ; Stefanoni, Patrizia ; Grassi, Guido ; Vergani, Carlo ; Mancia, Giuseppe. / Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia. In: Atherosclerosis. 1996 ; Vol. 124, No. 2. pp. 249-260.
@article{7fefe65a435640f7ab8265f9dea509af,
title = "Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia",
abstract = "Hypercholesterolemia impairs arteriolar dilatation, but whether the vascular abnormalities accompanying this condition include large artery function is unknown. We addressed this issue in 13 normotensive subjects with familial hypercholesterolemia (serum cholesterol 401.6 ± 16.9 mg/dl, mean ± S.E., FHC) and no evidence of atherosclerotic lesions, in whom radial artery (RA) diameter and blood pressure (BP) were measured beat to beat by an echotracking and a Finapres device, respectively. RA compliance (RAG) was derived from the diameter/BP relationship and expressed over the systo-diastolic BP range, both at baseline and after a 12-min brachial artery occlusion. RAC was expressed also as the area under the RAC/BP curve divided for pulse BP. Measurements included maximal forearm blood flow (plethysmography) and minimal forearm vascular resistance (FVR) which were obtained from the values following the 12-min brachial arterial occlusion. Data were collected before and after 6- and 24-month lipid lowering treatment (simvastatin 40 mg/day). Ten age-matched normotensive normocholesterolemic healthy subjects (N) served as controls. Compared to N, baseline RAC was strikingly reduced in FHC (-53.5{\%}, P <0.01). After ischemia RAC increased significantly and markedly in N (+38.7, P <0.01), while only a modest and non-significant increase was observed in FHC. Minimal FVR was markedly higher in FHC than in N (3.5 ± 0.9 vs 1.6 ± 0.1 units, P <0.01). In FHC (7 subjects) RAC remained unchanged after 6 months of lipid lowering treatment, but increased markedly (+55.2{\%}, P <0.05) when treatment was prolonged to 24 months. Lipid lowering treatment also reduced minimal FVR, the effect being significant bath after 6 and after 24 months. No changes in RAC and minimal FVR were seen after 6 months in controls. Thus, in subjects with a marked increase in serum cholesterol due to FHC, not only arteriolar dilatation, but also RAC and distensibility are markedly impaired. This impairment can be favourably affected by an effective lipid lowering treatment of long duration.",
keywords = "Arterial compliance, Familial hypercholesterolemia, Lipid profile, Peripheral circulation",
author = "Cristina Giannattasio and Mangoni, {Arduino A.} and Monica Failla and Stefano Carugo and Stella, {Maria Luisa} and Patrizia Stefanoni and Guido Grassi and Carlo Vergani and Giuseppe Mancia",
year = "1996",
month = "8",
day = "2",
doi = "10.1016/0021-9150(96)05834-0",
language = "English",
volume = "124",
pages = "249--260",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia

AU - Giannattasio, Cristina

AU - Mangoni, Arduino A.

AU - Failla, Monica

AU - Carugo, Stefano

AU - Stella, Maria Luisa

AU - Stefanoni, Patrizia

AU - Grassi, Guido

AU - Vergani, Carlo

AU - Mancia, Giuseppe

PY - 1996/8/2

Y1 - 1996/8/2

N2 - Hypercholesterolemia impairs arteriolar dilatation, but whether the vascular abnormalities accompanying this condition include large artery function is unknown. We addressed this issue in 13 normotensive subjects with familial hypercholesterolemia (serum cholesterol 401.6 ± 16.9 mg/dl, mean ± S.E., FHC) and no evidence of atherosclerotic lesions, in whom radial artery (RA) diameter and blood pressure (BP) were measured beat to beat by an echotracking and a Finapres device, respectively. RA compliance (RAG) was derived from the diameter/BP relationship and expressed over the systo-diastolic BP range, both at baseline and after a 12-min brachial artery occlusion. RAC was expressed also as the area under the RAC/BP curve divided for pulse BP. Measurements included maximal forearm blood flow (plethysmography) and minimal forearm vascular resistance (FVR) which were obtained from the values following the 12-min brachial arterial occlusion. Data were collected before and after 6- and 24-month lipid lowering treatment (simvastatin 40 mg/day). Ten age-matched normotensive normocholesterolemic healthy subjects (N) served as controls. Compared to N, baseline RAC was strikingly reduced in FHC (-53.5%, P <0.01). After ischemia RAC increased significantly and markedly in N (+38.7, P <0.01), while only a modest and non-significant increase was observed in FHC. Minimal FVR was markedly higher in FHC than in N (3.5 ± 0.9 vs 1.6 ± 0.1 units, P <0.01). In FHC (7 subjects) RAC remained unchanged after 6 months of lipid lowering treatment, but increased markedly (+55.2%, P <0.05) when treatment was prolonged to 24 months. Lipid lowering treatment also reduced minimal FVR, the effect being significant bath after 6 and after 24 months. No changes in RAC and minimal FVR were seen after 6 months in controls. Thus, in subjects with a marked increase in serum cholesterol due to FHC, not only arteriolar dilatation, but also RAC and distensibility are markedly impaired. This impairment can be favourably affected by an effective lipid lowering treatment of long duration.

AB - Hypercholesterolemia impairs arteriolar dilatation, but whether the vascular abnormalities accompanying this condition include large artery function is unknown. We addressed this issue in 13 normotensive subjects with familial hypercholesterolemia (serum cholesterol 401.6 ± 16.9 mg/dl, mean ± S.E., FHC) and no evidence of atherosclerotic lesions, in whom radial artery (RA) diameter and blood pressure (BP) were measured beat to beat by an echotracking and a Finapres device, respectively. RA compliance (RAG) was derived from the diameter/BP relationship and expressed over the systo-diastolic BP range, both at baseline and after a 12-min brachial artery occlusion. RAC was expressed also as the area under the RAC/BP curve divided for pulse BP. Measurements included maximal forearm blood flow (plethysmography) and minimal forearm vascular resistance (FVR) which were obtained from the values following the 12-min brachial arterial occlusion. Data were collected before and after 6- and 24-month lipid lowering treatment (simvastatin 40 mg/day). Ten age-matched normotensive normocholesterolemic healthy subjects (N) served as controls. Compared to N, baseline RAC was strikingly reduced in FHC (-53.5%, P <0.01). After ischemia RAC increased significantly and markedly in N (+38.7, P <0.01), while only a modest and non-significant increase was observed in FHC. Minimal FVR was markedly higher in FHC than in N (3.5 ± 0.9 vs 1.6 ± 0.1 units, P <0.01). In FHC (7 subjects) RAC remained unchanged after 6 months of lipid lowering treatment, but increased markedly (+55.2%, P <0.05) when treatment was prolonged to 24 months. Lipid lowering treatment also reduced minimal FVR, the effect being significant bath after 6 and after 24 months. No changes in RAC and minimal FVR were seen after 6 months in controls. Thus, in subjects with a marked increase in serum cholesterol due to FHC, not only arteriolar dilatation, but also RAC and distensibility are markedly impaired. This impairment can be favourably affected by an effective lipid lowering treatment of long duration.

KW - Arterial compliance

KW - Familial hypercholesterolemia

KW - Lipid profile

KW - Peripheral circulation

UR - http://www.scopus.com/inward/record.url?scp=0030564977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030564977&partnerID=8YFLogxK

U2 - 10.1016/0021-9150(96)05834-0

DO - 10.1016/0021-9150(96)05834-0

M3 - Article

C2 - 8830937

AN - SCOPUS:0030564977

VL - 124

SP - 249

EP - 260

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -